Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors

Alzheimer's and Dementia

Volumn 11, Issue 4, 2015, Pages 415-424

  Edmonds, Emily C ^a   Delano Wood, Lisa ^a,b   Clark, Lindsay R ^c   Jak, Amy J ^a,b   Nation, Daniel A ^d   McDonald, Carrie R ^a   Libon, David J ^e   Au, Rhoda ^f,g   Galasko, Douglas ^a,b,h   Salmon, David P ^h   Bondi, Mark W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g FRAMINGHAM HEART STUDY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimers disease; Cluster analysis; Dementia; MCI; Mild cognitive impairment; Misclassification; Misdiagnosis; Neuropsychology

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN; TAU181P PROTEIN; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); APOLIPOPROTEIN E4; BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; APOE EPSILON 4 GENE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; DIAGNOSTIC ERROR; FEMALE; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; CEREBROSPINAL FLUID; CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; FACTUAL DATABASE; GENETICS; MENTAL HEALTH; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E4; BIOMARKERS; CLUSTER ANALYSIS; DATABASES, FACTUAL; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84927173992     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.03.005     Document Type: Article

References (34)

1. R.C. Petersen Mild cognitive impairment as a diagnostic entity J Intern Med 256 2004 183 194
2. R.C. Petersen, and J.C. Morris Mild cognitive impairment as a clinical entity and treatment target Arch Neurol 62 2005 1160 1163
3. B. Winblad, K. Palmer, M. Kivipelto, V. Jelic, L. Fratiglioni, and L.O. Wahlund Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment J Intern Med 256 2004 240 246
4. L.R. Clark, L. Delano-Wood, D.J. Libon, C.R. McDonald, D.A. Nation, and K.J. Bangen Are empirically derived subtypes of mild cognitive impairment consistent with conventional subtypes? J Int Neuropsychol Soc 19 2013 1 11
5. L. Delano-Wood, M.W. Bondi, J. Sacco, N. Abeles, A.J. Jak, and D.J. Libon Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology J Int Neuropsychol Soc 15 2009 906 914
6. D.J. Libon, S.X. Xie, J. Eppig, G. Wicas, M. Lamar, and C. Lippa The heterogeneity of mild cognitive impairment: a neuropsychological analysis J Int Neuropsychol Soc 16 2010 84 93
7. M. Ganguli, B.E. Snitz, J.A. Saxton, C.C. Chang, C.W. Lee, and J. Vander Bilt Outcomes of mild cognitive impairment by definition: a population study Arch Neurol 68 2011 761 767
8. T.D. Koepsell, and S.E. Monsell Reversion from mild cognitive impairment to normal or near-normal cognition Neurology 79 2012 1591 1598
9. A. Nordlund, S. Rolstad, O. Klang, A. Edman, S. Hansen, and A. Wallin Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study J Neurol Neurosurg Psychiatry 81 2010 541 546
10. M.J. Summers, and N.L. Saunders Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment Neuropsychology 26 2012 498 508
11. S.L. Tyas, J.C. Salazar, D.A. Snowdon, M.F. Desrosiers, K.P. Riley, and M.S. Mendiondo Transitions to mild cognitive impairments, dementia, and death: findings from the nun study Am J Epidemiol 165 2007 1231 1238
12. R.C. Petersen, P. Aisen, B.F. Boeve, Y.E. Geda, R.J. Ivnik, and D.S. Knopman Criteria for mild cognitive impairment due to Alzheimer's disease in the community Ann Neurol 2013 http://dx.doi.org/10.1002/ana.23931 [Epub ahead of print]
13. R.C. Petersen, P.S. Aisen, L.A. Beckett, M.C. Donohue, A.C. Gamst, and D.J. Harvey Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 74 2010 201 209
14. D. Wechsler Wechsler memory scale-revised 1987 The Psychological Corporation New York
15. S.M. Landau, D. Harvey, C.M. Madison, E.M. Reiman, N.L. Foster, and P.S. Aisen Comparing predictors of conversion and decline in mild cognitive impairment Neurology 75 2010 230 238
16. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and J.B. Rimmler Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
17. R. Mayeux, Y. Stern, R. Ottman, T.K. Tatemichi, M.X. Tang, and G. Maestre The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease Ann Neurol 34 1993 752 754
18. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, and S.H. Joo Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472
19. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, and R.C. Petersen Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects Ann. Neurol 65 2009 403 413
20. J. Nettiksimmons, C. Decarli, S. Landau, and L. Beckett Biological heterogeneity in ADNI amnestic mild cognitive impairment Alzheimers Dement 2014 http://dx.doi.org/10.1016/j.jalz.2013.09.003 [Epub ahead of print]
21. B.L. Brooks, G.L. Iverson, and T. White Substantial risk of "accidental MCI" in healthy older adults: base rates of low memory scores in neuropsychological assessment J Int Neuropsychol Soc 13 2007 490 500
22. B.L. Brooks, G.L. Iverson, J.A. Holdnack, and H.H. Feldman Potential for misclassification of mild cognitive impairment: a study of memory scores on the Wechsler Memory Scale-III in healthy older adults J Int Neuropsychol Soc 14 2008 463 478
23. B.W. Palmer, K.B. Boone, I.M. Lesser, and M.A. Wohl Base rates of "impaired" neuropsychological test performance among healthy older adults Arch Clin Neuropsychol 13 1998 503 511
24. L.A. Rabin, N. Paré, A.J. Saykin, M.J. Brown, H.A. Wishart, and L.A. Flashman Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 16 2009 357 376
25. G. Tremont, A. Miele, M.M. Smith, and H.J. Westervelt Comparison of verbal memory impairment rates in mild cognitive impairment J Clin Exp Neuropsychol 32 2010 630 636
26. A.J. Mitchell A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment J Psychiatr Res 43 2009 411 431
27. J.C. Morris Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 1993 2412 2414
28. Y.L. Chang, M.W. Bondi, L.K. McEvoy, C. Fennema-Notestine, D.P. Salmon, and D. Galasko Global clinical dementia rating of 0.5 in MCI masks variability related to level of function Neurology 76 2011 652 659
29. J. Saxton, B.E. Snitz, O.L. Lopez, D.G. Ives, L.O. Dunn, and A. Fitzpatrick Functional and cognitive criteria produce different rates of MCI and conversion to dementia J Neurol Neurosurg Psychiatry 80 2009 737 743
30. L.M. Reid, and A.M. MacLullich Subjective memory complaints and cognitive impairment in older people Dement Geriatr Cogn Disord 22 2006 471 485
31. T.T. Lineweaver, M.W. Bondi, D. Galasko, and D.P. Salmon Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults Am J Psychiatry 171 2014 201 208
32. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
33. M. Sliwinski, R.B. Lipton, H. Buschke, and W. Stewart The effects of preclinical dementia on estimates of normal cognitive functioning in aging J Gerontol B Psychol Sci Soc Sci 51 1996 P217 P225
34. A.J. Jak, M.W. Bondi, L. Delano-Wood, C. Wierenga, J. Corey-Bloom, and D.P. Salmon Quantification of five neuropsychological approaches to defining mild cognitive impairment Am J Geriatr Psychiatry 17 2009 368 375